83930-13-6
Name | GRF (1-44) (HUMAN) |
CAS | 83930-13-6 |
Molecular Formula | C215H358N72O66S |
MDL Number | MFCD00081671 |
Molecular Weight | 5039.65 |
MOL File | 83930-13-6.mol |
Synonyms
HPGRF
SOMATORELIN
GRF (HUMAN)
GHRH (HUMAN)
HPGRF, HUMAN
GRF Acetate
SOMATOLIBERIN
GHRF (1-44) HUMAN
GHFR (1-44), HUMAN
GHRH (1-44), HUMAN
GRF (1-44) (HUMAN)
GRF(human) Acetate
SERMORELIN (HUMAN)
Somatorelin Acetate
SOMATOCRININ (HUMAN)
SOMATOLIBERIN (HUMAN)
GRF (1-44), AMIDE, HUMAN
GRF (1-44) (HUMAN) USP/EP/BP
GRF (human)|GHRF (1-44), human
M.W. 5039.72 C215H358N72O66S
Growth-hormone-releasing hormone
Human growth hormone-releasing factor
GROWTH HORMONE RELEASING FACTOR, HUMAN
GROWTH HORMONE-RELEASING HORMONE (HUMAN)
YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL
GROWTH HORMONE RELEASING FACTOR (1-44), HUMAN
YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
Human growth hormone-releasing hormone (1-44) amide
Growth hormone releasing factor, human, ≥95% (HPLC)
GROWTH HORMONE RELEASING FACTOR (1-44), AMIDE, HUMAN
Growth HorMone Releasing Factor huManGrowth HorMone Releasing Fa
SoMatoliberin (huMan), SoMatocrinin (huMan), SoMatorelin (huMan), Growth HorMone-Releasing Factor (huMan), Growth HorMone-Releasing HorMone (huMan), GHRH (huMan), SoMatorelin
TYR-ALA-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-LEU-SER-ALA-ARG-LYS-LEU-LEU-GLN-ASP-ILE-MET-SER-ARG-GLN-GLN-GLY-GLU-SER-ASN-GLN-GLU-ARG-GLY-ALA-ARG-ALA-ARG-LEU-NH2
H-TYR-ALA-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-LEU-SER-ALA-ARG-LYS-LEU-LEU-GLN-ASP-ILE-MET-SER-ARG-GLN-GLN-GLY-GLU-SER-ASN-GLN-GLU-ARG-GLY-ALA-ARG-ALA-ARG-LEU-OH
H-TYR-ALA-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-LEU-SER-ALA-ARG-LYS-LEU-LEU-GLN-ASP-ILE-MET-SER-ARG-GLN-GLN-GLY-GLU-SER-ASN-GLN-GLU-ARG-GLY-ALA-ARG-ALA-ARG-LEU-NH2
H-Tyr-Ala-Asp-Ala-Lle-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-lys-Leu-Leu-Gln-Asp-Lle-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
GRF (huMan)
SoMatoliberin (huMan), SoMatocrinin (huMan), SoMatorelin (huMan), Growth HorMone-Releasing Factor (huMan), Growth HorMone-Releasing HorMone (huMan), GHRH (huMan), SoMatorelin
H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
acetate salt
Chemical Properties
storage temp. | −20°C |
form | powder |
color | White to off-white |
Water Solubility | Water : 25 mg/mL (4.96 mM) |
Hazard Information
Description
GHRH is expressed and secreted from the hypothalamic
neurons of the arcuate nucleus (ARC). GHRH stimulates
the release of growth hormone (GH) in the anterior
pituitary. In 1982, three isoforms of GHRH(1–37, 1–40, 1–44 aa
residues) were initially isolated from human pancreatic
tumors that caused acromegaly, and the latter two were
found in the human hypothalamus. The aa sequence of
GHRH was also identified in various vertebrates from
rodents to fish, including a protochordate. In nonmammalian vertebrates, GHRH-like peptide (pituitary adenylate cyclase-activating polypeptide (PACAP)-related
peptide in mammals) was first isolated like GHRH,
although the GHRH-like peptide had less activity on
GH release. Later, actual GHRH, which was more phylogenetically and structurally similar to mammalian
GHRH and showed GH-releasing activity, was isolated
in nonmammalian vertebrates.
Clinical Use
Sermorelin, a functional peptide fragment of GHRH
(1–29), has been used in the diagnosis and treatment of
children with idiopathic growth hormone deficiency. Tesamorelin, a stabilized synthetic peptide analog of
GHRH(1–44), received US Food and Drug Administration approval in 2010 for the treatment of lipodystrophy
in HIV patients under highly active antiretroviral therapy, and was investigated for effects on certain cognitive
functions in adults with cognitive impairment as well as
healthy older adults.
storage
Store at -20°C
Questions And Answer
-
Structure
GHRH(1–29) is the bioactive core of human GHRH. The N-terminal tyrosine residue with selected aromatic rings is important for the high bioactivity in human and nonrodent mammalian GHRH. The amino acid sequence of GHRH shows higher identities between the human, porcine, bovine, and caprine species, but the rat and mouse are exceptions. The sequence of the C-terminus is highly variable among species while the N-terminus is more conserved. The N-terminal region (1–27) of GHRH is well conserved in nonmammalian vertebrates. Zebrafish GHRH (1–27) shows 74.1%, 81.5%, and 81.5% similarity to the Xenopus tropicalis, chicken, and human counterparts, respectively. Mr 12,447 (GHRH(1-44), Mr 5,039), pI 10.3 (GHRH(1- 44), pI 11.5). Soluble in acidic aqueous solution (e.g., 1% acetic acid). Lyophilized GHRH is stable at room temperature for 2months, and recommended storage is below -18°C with desiccation.; -
Gene, mRNA, and precursor
The human GHRH gene, GHRH, location 20q11.2, consists of five exons. GHRH mRNA has 459 bases that encode a signal peptide of 24 aa residues, a mature protein of 44 aa residues, and a C-peptide of 31 aa residues with unknown function. In nonmammalian vertebrates, the GHRH-like peptide and PACAP were first believed to be encoded by the same gene, but later actual GHRH and PACAP were found to be encoded by two distinct genes.; -
Synthesis and release
The human GHRH gene, GHRH, location 20q11.2, consists of five exons. GHRH mRNA has 459 bases that encode a signal peptide of 24 aa residues, a mature protein of 44 aa residues, and a C-peptide of 31 aa residues with unknown function. In nonmammalian vertebrates, the GHRH-like peptide and PACAP were first believed to be encoded by the same gene, but later actual GHRH and PACAP were found to be encoded by two distinct genes.; -
Synthesis and release
The synthesis and release of GHRH are regulated by sex hormones, aging, the negative feedback effect of GH, and diverse pathological conditions. Gsh-1 has been considered a transcriptional factor of Ghrh expression in the rat hypothalamus. GHRH synthesis is inhibited by somatostatin (SS). The expression levels of the SS receptor, sst2A, in GHRH neurons are higher in female mice than male mice. The production of hypothalamic GHRH is decreased by aging. It is also negatively regulated by the feedback of GH, whereas ghrelin stimulates GHRH release.; -
Receptors
GHRH-R belongs to the GPCR B II subclass, highly selective for GHRH. The GHRH-R of most mammals consists of 423 aa residues. The N-terminal extracellular domain contains a site for N-glycosylation as well as six cysteine residues and an aspartate residue that are conserved in this receptor family. The third intracellular loop and the C-terminal intracellular domain contain several potential phosphorylation sites, which may regulate signaling and receptor internalization. It is mainly expressed in the pituitary.; -
Agonists and Antagonists
Tesamorelin, sermorelin (GHRH(1–29)-NH2), and CJC-1295 are agonists. Antagonists comprise the antibodies or peptides to GHRH-R: JV-1-10, JV-1-36, JV-1-37, JV-1-38, JV-1-39, JV-1-40, JV-1-41, JV-1-42, JV-1-43, JV-1-62, JV-1-63, MZ-4-71, MZ-4-169, MZ-4-181, MZ-4-243, MZ-5-78, MZ-5-156, MZ-5-192, MZ-6-55, [Ac-Tyr1, D-Arg2] GHRH(1–29)-NH2.; -
Biological functions
GHRH receptor mRNA is expressed in several organs, especially in the adrenal, digestive tract, and kidney. The primary function of GHRH is to stimulate GH synthesis and release from the anterior pituitary somatotrophs. GHRH activates cell proliferation, cell differentiation, and growth of somatotrophs, and is also involved in the modulation of appetite and feeding behavior, the regulation of sleeping, the control of jejunal motility, and the increase in leptin levels in modest obesity .; -
Clinical implications
Mutations in the GHRH gene have never been described. A single base change in the GHRH-R gene in human somatotropinoma confers hypersensitivity to GHRH binding. Pit-1 mutation inducing the low gene expression of GHRH-R can lead to the development of dwarfism.;
Supplier
J & K SCIENTIFIC LTD.
Telephone010-82848833 400-666-7788
Websitehttp://www.jkchemical.com
Alabiochem Tech.Co., Ltd.
Telephone512-58900862 400-0707518
Websitehttp://cn.alabiochem.com.cn
Shanghai Hanhong Scientific Co.,Ltd.
Telephone021-54306202 13764082696
Websitehttps://www.hanhongsci.com
Chemsky(shanghai)International Co.,Ltd.
Telephone021-50135380
Websitehttp://www.shchemsky.com
Lavem Chine Pharm Company
Telephone28-86066080 18280039962
Websitehttp://www.lavemc.com/
Cellmano Biotech Limited
Telephone0551-65326643 18156095617
Websitehttps://www.cellmano.com
Beijing HuaMeiHuLiBiological Chemical
Telephone010-56205725
Websitehttp://www.huabeibiochem.com/
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Telephone400-400-6206333 18521732826
Websitehttp://www.aladdin-e.com/
Chengdu HuaXia Chemical Reagent Co. Ltd
Telephone400-1166-196 13458535857
Websitehttp://www.hx-r.com
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Telephone0510-85629785 18013409632
Websitehttp://www.reading-chemicals.com
NINGBO INNO PHARMCHEM CO.,LTD.
Telephone86-574-27787657
Websitehttp://www.dearchem.com
Shanghai YuLue Chemical Co., Ltd.
Telephone021-60345187 13671753212
Websitehttps://www.chemicalbook.com/ShowSupplierProductsList16365/0.htm
Shanghai HuanChuan Industry Co.,Ltd.
Telephone021-61478794
Websitehttp://www.hcshhai.com
Credit Asia Chemical Co., Ltd.
Telephone+86 (21) 61124340
Websitehttps://www.chemicalbook.com/ShowSupplierProductsList16523/0.htm
LETOPHARM LIMITED
Telephone+86-21-5821 5861
Websitehttp://www.letopharm.com
Codow Chemical Co.,Ltd.
Telephone 18620099427
Websitehttp://www.howeipharm.com
Jinan Putubio Tech Co., Ltd.
Telephone+86 (531) 8099-2215
Websitehttps://www.chemicalbook.com/ShowSupplierProductsList16923/0.htm
Shanghai Xilong Biochemical Technology Co., Ltd.
Telephone021-52907766-8042
Websitehttps://www.chemicalbook.com/ShowSupplierProductsList19329/0.htm
1of4
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China
The What'sApp is temporarily not supported in mainland China
Cancel
Determine